IntelliSpace Portal 8.0 platform for the treatment of Cancer

Royal Philips' IntelliSpace Portal 8.0 helps address the changing demands in radiology that result from an increasing prevalence of cancer and its economic toll. It delivers new applications, like fast 3-D quantitative renderings of tumors, in a fully integrated oncology suite to improve diagnostic confidence and patient care. A key but challenging clinical need for today's radiologists is determining how tumors are reacting to new local image guided treatment approaches, such as tumor ablation and chemoembolization. Currently, this is done by evaluating 1-D or 2-D MRI-images taken after the procedure, which give only limited insight and no quantified information. With the growing interest in finding new 3-D quantification options, IntelliSpace Portal 8.0 now includes, as an option for qualified researchers, a quantitative technology (qEASL), which can be used in conjunction with its Multi-Modality Tumor Tracking (MMTT) application. With this technology, researchers can make a specialized analysis of 3-D imaging scans (e.g. CT and MRI) with the aim to enhance measurement of living and dying tumor tissue by giving them a visual indication of how cells respond to therapy.